Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study.
Reck M, Dziadziuszko R, Sugawara S, Kao S, Hochmair M, Huemer F, de Castro G Jr, Havel L, Bernabé Caro R, Losonczy G, Lee JS, Kowalski DM, Andric Z, Califano R, Veatch A, Gerstner G, Batus M, Morris S, Kaul M, Cuchelkar V, Li H, Danner BJ, Nabet BY, Liu SV.
Reck M, et al. Among authors: gerstner g.
Lung Cancer. 2024 Aug 10;196:107924. doi: 10.1016/j.lungcan.2024.107924. Online ahead of print.
Lung Cancer. 2024.
PMID: 39306923